Connor Arkinson
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Structural and Biochemical Insights into the Mechanism of Action of the Clinical USP1 Inhibitor, KSQ-4279.
Journal: Journal of medicinal chemistry
Published: August 27, 2024
Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site.
Journal: Science advances
Published: September 28, 2022
Structural and biochemical basis of interdependent FANCI-FANCD2 ubiquitination.
Journal: The EMBO journal
Published: June 16, 2022
Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination.
Journal: The FEBS journal
Published: April 21, 2021
Structural basis of FANCD2 deubiquitination by USP1-UAF1.
Journal: Nature structural & molecular biology
Published: November 12, 2020
Differential functions of FANCI and FANCD2 ubiquitination stabilize ID2 complex on DNA.
Journal: EMBO reports
Published: January 31, 2020
Allosteric mechanism for site-specific ubiquitination of FANCD2.
Journal: Nature chemical biology
Published: March 28, 2019
Enzymatic preparation of monoubiquitinated FANCD2 and FANCI proteins.
Journal: Methods in enzymology
Published: March 10, 2019
Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1.
Journal: Life science alliance
Published: August 15, 2018
Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening.
Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening.
Journal: Journal of medicinal chemistry
Published: April 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026